Skip to main content

Flurazepam Hydrochloride Capsule Shortage

Last Updated: August 19, 2025
Status: Current

Unavailable, Current:

Available, Current:

Flurazepam Hydrochloride, Capsule, 15 mg (Rising Pharma Holdings, Inc.)

NDC Code: 0378-4415-01
Availability: Unavailable
Status: Current
Date of update: August 19, 2025
Update type: Reverified
Reason for shortage: Regulatory delay
Related Information: Anticipated availability: Q3 2025; Delay is due to manufacturing delays at the contract manufacturing facility.
Therapeutic category: Neurology; Other
Initial posting date: August 3, 2022
Contact info: 1-844-874-7464

Flurazepam Hydrochloride, Capsule, 30 mg (Rising Pharma Holdings, Inc.)

NDC Code: 0378-4430-01
Availability: Unavailable
Status: Current
Date of update: August 19, 2025
Update type: Reverified
Reason for shortage: Regulatory delay
Related Information: Anticipated availability: Q3 2025; Delay is due to manufacturing delays at the contract manufacturing facility.
Therapeutic category: Neurology; Other
Initial posting date: August 3, 2022
Contact info: 1-844-874-7464

Flurazepam Hydrochloride, Capsule, 15 mg (Chartwell Molecular Holdings LLC)

NDC Code: 62135-736-30
Availability: Available
Status: Current
Date of update: August 19, 2025
Update type: Reverified
Therapeutic category: Neurology; Other
Initial posting date: August 3, 2022
Contact info: 845-268-5000 Ext. 510

Flurazepam Hydrochloride, Capsule, 15 mg (Chartwell Molecular Holdings LLC)

NDC Code: 62135-736-90
Availability: Available
Status: Current
Date of update: August 19, 2025
Update type: Reverified
Therapeutic category: Oncology; Other
Initial posting date: August 3, 2022
Contact info: 845-268-5000 Ext. 510

Flurazepam Hydrochloride, Capsule, 30 mg (Chartwell Molecular Holdings LLC)

NDC Code: 62135-737-30
Availability: Available
Status: Current
Date of update: August 19, 2025
Update type: Reverified
Therapeutic category: Neurology; Other
Initial posting date: August 3, 2022
Contact info: 845-268-5000 Ext. 510

Flurazepam Hydrochloride, Capsule, 30 mg (Chartwell Molecular Holdings LLC)

NDC Code: 62135-737-90
Availability: Available
Status: Current
Date of update: August 19, 2025
Update type: Reverified
Therapeutic category: Neurology; Other
Initial posting date: August 3, 2022
Contact info: 845-268-5000 Ext. 510

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer